View Past PerformanceThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCannagistics バランスシートの健全性財務の健全性 基準チェック /06Cannagisticsの健全性を判断するにはデータが不十分です主要情報n/a負債資本比率n/a負債インタレスト・カバレッジ・レシオn/a現金n/aエクイティn/a負債合計n/a総資産n/a財務の健全性に関する最新情報お知らせ • Nov 03Cannagistics, Inc. announced delayed annual 10-K filingOn 11/02/2022, Cannagistics, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jun 15Cannagistics, Inc. announced delayed 10-Q filingOn 06/14/2022, Cannagistics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Dec 16Cannagistics Inc. announced delayed 10-Q filingOn 12/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 17Cannagistics Inc. announced delayed 10-Q filingOn 06/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Mar 17Cannagistics Inc. announced delayed 10-Q filingOn 03/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Dec 17Cannagistics Inc. announced delayed 10-Q filingOn 12/15/2020, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.すべての更新を表示Recent updatesお知らせ • Nov 03Cannagistics, Inc. announced delayed annual 10-K filingOn 11/02/2022, Cannagistics, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 17+ 1 more updateCannagistics, Inc. Announces Executive and Board ChangesEffective as of August 15, 2022, Cannagistics, Inc. announced the resignation of Dr. Babik Ghalili as Director and Jim Morrison as President. The company appointed Jim Morrison as Director and James W. Zimbler as Director and Interim President. Mr. Zimbler has served as the Registrant's Vice President of Corporate Finance since November 2021, and prior was the President. He served as a director of the Company from since November 2017 to November 2021. Previously, from November 17, 2017, until July 1, 2020, he served as President of the Company in which role he was responsible for strategic decision making, capital expenditure planning and staffing matters. From December 2017 until June 2019, he served as President and a director of the predecessor iteration of a public company that is now Enzolytics, Inc., a drug development company. In December 2016 he founded Emerging Growth Advisors, Inc., a consulting firm providing advisory services related to mergers and acquisitions for corporations including the Company, and now Emerging Capital Strategies Ltd., where he has served as President since formation. Prior to founding Emerging Growth Advisors, Inc., Mr. Zimbler served in a managerial role at other consulting firms, each specializing in mergers and acquisitions, roll ups and turn-around work.お知らせ • Jun 15Cannagistics, Inc. announced delayed 10-Q filingOn 06/14/2022, Cannagistics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Dec 16Cannagistics Inc. announced delayed 10-Q filingOn 12/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 27Cannagistics Inc. announced that it has received $0.1 million in funding from GW Holdings Group, LLCOn August 25, 2021, Cannagistics Inc. closed the transaction.お知らせ • Jun 17Cannagistics Inc. announced delayed 10-Q filingOn 06/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Mar 17Cannagistics Inc. announced delayed 10-Q filingOn 03/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 29Cannagistics Inc. (OTCPK:CNGT) entered into a Binding Letter of Intent to acquire Recommerce Group, Inc.Cannagistics Inc. (OTCPK:CNGT) entered into a Binding Letter of Intent to acquire Recommerce Group, Inc. on January 26, 2021. The closing is based upon completion of proper due diligence by the parties and agreement on definitive documents as well as the necessary funding being in place. The closing is to be targeted to take place on or about March 31, 2021. Pursuant to the Letter of Intent, both parties may extend the date of closing upon mutual agreement.お知らせ • Dec 17Cannagistics Inc. announced delayed 10-Q filingOn 12/15/2020, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Oct 30Cannagistics Inc. announced delayed annual 10-K filingOn 10/29/2020, Cannagistics Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Sep 22Cannagistics Inc. (OTCPK:CNGT) signed a letter of intent to acquire assets of Unified Cannabis Corp.Cannagistics Inc. (OTCPK:CNGT) signed a letter of intent to acquire assets of Unified Cannabis Corp on September 18, 2019. Under the transaction, Unified will merge qualified assets into Cannagistics, in an all-stock transaction. Follow the transaction, Unified will be appointing three members to the Cannagistics board including its chairman, Jonathan Denis. The transaction is subject to due diligence, regulatory, funder and other transactional approvals. The transaction's first stage of asset closing is expected this month with subsequent closings.お知らせ • Jul 10Cannagistics Inc. Announces Executive ChangesEffective as of July 1, 2020, the following has resigned as CEO of Cannagistics Inc. James W. Zimbler as CEO. Mr. Zimbler remains on the Board of Directors of the company. Effective as of July 1, 2020, the following individual(s) were elected as Officers and to the Board of Directors of the company: Rob Gietl, CEO. Rob Gietl was most recently, Until March 2020 the Interim CEO of Availa Bio Inc. From April 2017 to February 2019, Mr. Gietl was CEO of MYM Nutraceuticals Inc. He previously served from September 2015 to March 2017 as the Director of Business Development at NRI Global Inc. where he led industrial acquisitions, environmental remediation and global sales of reusable assets and commodities.このセクションでは、通常、Cannagistics'の財務の健全性を分析し、財務上の苦境に陥った時に対してどの程度有利な立場にあるか、特に現金と負債レベルの管理能力を判断する。Cannagistics は、適切な貸借対照表データを提供していないため、財務の健全性を適切に評価することはできない。シンプリー・ウォール・ストリートがカバーする企業の97%は財務情報を持っているので、これはかなり稀な状況である。財務状況分析短期負債: CNGTの 短期資産 が 短期負債 をカバーしているかどうかを判断するにはデータが不十分です。長期負債: CNGTの短期資産が 長期負債 をカバーしているかどうかを判断するにはデータが不十分です。デット・ツー・エクイティの歴史と分析負債レベル: CNGTの 純負債対資本比率 を計算して 満足できる ものであるかどうかを判断するにはデータが不十分です。負債の削減: CNGTの負債対資本比率が過去 5 年間で減少したかどうかを判断するにはデータが不十分です。債務返済能力: CNGTの負債が 営業キャッシュフロー によって 十分にカバーされている かどうかを判断するにはデータが不十分です。インタレストカバレッジ: CNGTの負債に対する 利息支払い が EBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YTransportation 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/03/11 04:08終値2025/02/04 00:00収益2022/04/30年間収益2021/07/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cannagistics, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Nov 03Cannagistics, Inc. announced delayed annual 10-K filingOn 11/02/2022, Cannagistics, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jun 15Cannagistics, Inc. announced delayed 10-Q filingOn 06/14/2022, Cannagistics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Dec 16Cannagistics Inc. announced delayed 10-Q filingOn 12/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 17Cannagistics Inc. announced delayed 10-Q filingOn 06/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Mar 17Cannagistics Inc. announced delayed 10-Q filingOn 03/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Dec 17Cannagistics Inc. announced delayed 10-Q filingOn 12/15/2020, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 03Cannagistics, Inc. announced delayed annual 10-K filingOn 11/02/2022, Cannagistics, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 17+ 1 more updateCannagistics, Inc. Announces Executive and Board ChangesEffective as of August 15, 2022, Cannagistics, Inc. announced the resignation of Dr. Babik Ghalili as Director and Jim Morrison as President. The company appointed Jim Morrison as Director and James W. Zimbler as Director and Interim President. Mr. Zimbler has served as the Registrant's Vice President of Corporate Finance since November 2021, and prior was the President. He served as a director of the Company from since November 2017 to November 2021. Previously, from November 17, 2017, until July 1, 2020, he served as President of the Company in which role he was responsible for strategic decision making, capital expenditure planning and staffing matters. From December 2017 until June 2019, he served as President and a director of the predecessor iteration of a public company that is now Enzolytics, Inc., a drug development company. In December 2016 he founded Emerging Growth Advisors, Inc., a consulting firm providing advisory services related to mergers and acquisitions for corporations including the Company, and now Emerging Capital Strategies Ltd., where he has served as President since formation. Prior to founding Emerging Growth Advisors, Inc., Mr. Zimbler served in a managerial role at other consulting firms, each specializing in mergers and acquisitions, roll ups and turn-around work.
お知らせ • Jun 15Cannagistics, Inc. announced delayed 10-Q filingOn 06/14/2022, Cannagistics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Dec 16Cannagistics Inc. announced delayed 10-Q filingOn 12/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 27Cannagistics Inc. announced that it has received $0.1 million in funding from GW Holdings Group, LLCOn August 25, 2021, Cannagistics Inc. closed the transaction.
お知らせ • Jun 17Cannagistics Inc. announced delayed 10-Q filingOn 06/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Mar 17Cannagistics Inc. announced delayed 10-Q filingOn 03/15/2021, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 29Cannagistics Inc. (OTCPK:CNGT) entered into a Binding Letter of Intent to acquire Recommerce Group, Inc.Cannagistics Inc. (OTCPK:CNGT) entered into a Binding Letter of Intent to acquire Recommerce Group, Inc. on January 26, 2021. The closing is based upon completion of proper due diligence by the parties and agreement on definitive documents as well as the necessary funding being in place. The closing is to be targeted to take place on or about March 31, 2021. Pursuant to the Letter of Intent, both parties may extend the date of closing upon mutual agreement.
お知らせ • Dec 17Cannagistics Inc. announced delayed 10-Q filingOn 12/15/2020, Cannagistics Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Oct 30Cannagistics Inc. announced delayed annual 10-K filingOn 10/29/2020, Cannagistics Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Sep 22Cannagistics Inc. (OTCPK:CNGT) signed a letter of intent to acquire assets of Unified Cannabis Corp.Cannagistics Inc. (OTCPK:CNGT) signed a letter of intent to acquire assets of Unified Cannabis Corp on September 18, 2019. Under the transaction, Unified will merge qualified assets into Cannagistics, in an all-stock transaction. Follow the transaction, Unified will be appointing three members to the Cannagistics board including its chairman, Jonathan Denis. The transaction is subject to due diligence, regulatory, funder and other transactional approvals. The transaction's first stage of asset closing is expected this month with subsequent closings.
お知らせ • Jul 10Cannagistics Inc. Announces Executive ChangesEffective as of July 1, 2020, the following has resigned as CEO of Cannagistics Inc. James W. Zimbler as CEO. Mr. Zimbler remains on the Board of Directors of the company. Effective as of July 1, 2020, the following individual(s) were elected as Officers and to the Board of Directors of the company: Rob Gietl, CEO. Rob Gietl was most recently, Until March 2020 the Interim CEO of Availa Bio Inc. From April 2017 to February 2019, Mr. Gietl was CEO of MYM Nutraceuticals Inc. He previously served from September 2015 to March 2017 as the Director of Business Development at NRI Global Inc. where he led industrial acquisitions, environmental remediation and global sales of reusable assets and commodities.